%PDF-1.4
1 0 obj
<<
/Type /Catalog
/Pages 2 0 R
>>
endobj

2 0 obj
<<
/Type /Pages
/Kids [3 0 R]
/Count 1
>>
endobj

3 0 obj
<<
/Type /Page
/Parent 2 0 R
/MediaBox [0 0 612 792]
/Contents 4 0 R
/Resources <<
/Font <<
/F1 5 0 R
>>
>>
>>
endobj

4 0 obj
<<
/Length 2100
>>
stream
BT
/F1 10 Tf
50 750 Td
(EXPERT WITNESS REPORT) Tj
200 0 Td
(CONFIDENTIAL) Tj
-200 -30 Td
(FORENSIC ACCOUNTING ANALYSIS) Tj
0 -30 Td
(Case: Peterson v. Lucky Strike Tobacco Company) Tj
0 -15 Td
(Expert: Dr. Michael Harrison, CPA, CFE, CFF) Tj
0 -15 Td
(Date: February 10, 2025) Tj
0 -30 Td
(EXPERT QUALIFICATIONS:) Tj
0 -20 Td
(- Ph.D. in Accounting, Stanford University) Tj
0 -15 Td
(- Certified Public Accountant (CPA) - 25 years) Tj
0 -15 Td
(- Certified Fraud Examiner (CFE)) Tj
0 -15 Td
(- Certified in Financial Forensics (CFF)) Tj
0 -15 Td
(- Former SEC Senior Investigator (1995-2005)) Tj
0 -15 Td
(- Testified in over 150 federal and state court cases) Tj
0 -15 Td
(- Published 45 articles on forensic accounting) Tj
0 -15 Td
(- Professor of Forensic Accounting, NYU Stern School) Tj
0 -30 Td
(ASSIGNMENT:) Tj
0 -20 Td
(I was retained by plaintiff's counsel to analyze the financial) Tj
0 -15 Td
(records and accounting practices of Lucky Strike Tobacco) Tj
0 -15 Td
(Company for the period 1970-2010 to determine:) Tj
0 -15 Td
(1. Whether the company concealed health research costs) Tj
0 -15 Td
(2. The economic benefit derived from non-disclosure) Tj
0 -15 Td
(3. Appropriate disgorgement and restitution amounts) Tj
0 -30 Td
(DOCUMENTS REVIEWED:) Tj
0 -20 Td
(1. Audited financial statements (1970-2010)) Tj
0 -15 Td
(2. General ledger and subsidiary accounts) Tj
0 -15 Td
(3. Research and development expenditure records) Tj
0 -15 Td
(4. Internal accounting memoranda and policies) Tj
0 -15 Td
(5. Board meeting minutes regarding research) Tj
0 -15 Td
(6. SEC filings and quarterly reports) Tj
0 -15 Td
(7. Insurance policies and claims documentation) Tj
0 -15 Td
(8. Marketing and advertising expenditure records) Tj
0 -15 Td
(9. Legal settlement and judgment payments) Tj
0 -15 Td
(10. Stock price and trading volume data) Tj
0 -30 Td
(METHODOLOGY:) Tj
0 -20 Td
(1. Comparative analysis with industry accounting standards) Tj
0 -15 Td
(2. Trend analysis of research expenditures vs. disclosures) Tj
0 -15 Td
(3. Statistical correlation between research findings and stock performance) Tj
0 -15 Td
(4. Present value calculations of economic benefits) Tj
0 -15 Td
(5. Market impact analysis of disclosure timing) Tj
0 -30 Td
(KEY FINDINGS:) Tj
0 -20 Td
(1. CONCEALED RESEARCH EXPENDITURES:) Tj
0 -15 Td
(Analysis reveals that Lucky Strike systematically) Tj
0 -15 Td
(misclassified health research costs as "general) Tj
0 -15 Td
(administrative expenses" rather than R&D:) Tj
0 -15 Td
(- 1970-1979: $47.3 million misclassified) Tj
0 -15 Td
(- 1980-1989: $89.7 million misclassified) Tj
0 -15 Td
(- 1990-1999: $156.4 million misclassified) Tj
0 -15 Td
(- 2000-2010: $203.8 million misclassified) Tj
0 -15 Td
(Total Concealed Research: $497.2 million) Tj
0 -20 Td
(2. ECONOMIC BENEFIT ANALYSIS:) Tj
0 -15 Td
(The company's concealment of negative health research) Tj
0 -15 Td
(results provided substantial economic benefits:) Tj
0 -15 Td
(a) Avoided stock price decline: $2.3 billion) Tj
0 -15 Td
(b) Continued market share: $1.8 billion) Tj
0 -15 Td
(c) Reduced insurance costs: $340 million) Tj
0 -15 Td
(d) Avoided regulatory compliance: $560 million) Tj
0 -15 Td
(Total Economic Benefit: $5.0 billion) Tj
0 -20 Td
(3. STOCK MARKET IMPACT:) Tj
0 -15 Td
(Regression analysis shows strong correlation between) Tj
0 -15 Td
(concealment periods and stock performance:) Tj
0 -15 Td
(- Stock price premium: 23-31% above fair value) Tj
0 -15 Td
(- Market capitalization inflation: $3.2 billion) Tj
0 -15 Td
(- Dividend payments from ill-gotten gains: $890 million) Tj
0 -20 Td
(4. ACCOUNTING VIOLATIONS:) Tj
0 -15 Td
(The company's practices violated multiple accounting principles:) Tj
0 -15 Td
(- GAAP requirements for research disclosure) Tj
0 -15 Td
(- SEC materiality standards for adverse findings) Tj
0 -15 Td
(- Sarbanes-Oxley internal control requirements) Tj
0 -15 Td
(- Generally accepted auditing standards) Tj
0 -30 Td
(CALCULATED DAMAGES:) Tj
0 -20 Td
(Based on economic analysis, appropriate remedies include:) Tj
0 -15 Td
(1. DISGORGEMENT OF ILL-GOTTEN GAINS:) Tj
0 -15 Td
(Present value of economic benefits: $5.0 billion) Tj
0 -15 Td
(Adjusted for time value of money: $7.8 billion) Tj
0 -15 Td
(2. PREJUDGMENT INTEREST:) Tj
0 -15 Td
(Compound interest at federal rate: $2.1 billion) Tj
0 -15 Td
(3. RESTITUTION TO SHAREHOLDERS:) Tj
0 -15 Td
(Excess dividends paid from concealed profits: $890 million) Tj
0 -15 Td
(4. CONSUMER RESTITUTION:) Tj
0 -15 Td
(Overcharges during concealment period: $1.2 billion) Tj
0 -15 Td
(TOTAL RECOMMENDED AWARD: $11.99 billion) Tj
0 -30 Td
(EXPERT OPINIONS:) Tj
0 -20 Td
(1. Lucky Strike's accounting practices deliberately) Tj
0 -15 Td
(concealed material adverse research findings) Tj
0 -15 Td
(2. The concealment provided substantial economic benefits) Tj
0 -15 Td
(3. Shareholders and consumers were harmed by the deception) Tj
0 -15 Td
(4. Full disgorgement is necessary to eliminate unjust enrichment) Tj
0 -15 Td
(5. The company's financial statements were materially misleading) Tj
0 -30 Td
(ASSUMPTIONS AND LIMITATIONS:) Tj
0 -20 Td
(1. Analysis based on available company records) Tj
0 -15 Td
(2. Market data from public sources) Tj
0 -15 Td
(3. Industry comparisons limited to public companies) Tj
0 -15 Td
(4. Discount rates based on contemporary Treasury rates) Tj
0 -15 Td
(5. Future economic impact not quantified) Tj
0 -30 Td
(I reserve the right to supplement this report based on) Tj
0 -15 Td
(additional discovery or changed circumstances.) Tj
0 -40 Td
(Dr. Michael Harrison, CPA, CFE, CFF) Tj
0 -15 Td
(Forensic Accounting Expert) Tj
0 -15 Td
(Harrison Forensic Consulting LLC) Tj
0 -15 Td
(Phone: (212) 555-0147) Tj
0 -15 Td
(Email: mharrison@harrisonforensic.com) Tj
0 -30 Td
(Exhibits:) Tj
0 -15 Td
(A - Financial Statement Analysis) Tj
0 -15 Td
(B - Research Expenditure Tracking) Tj
0 -15 Td
(C - Stock Price Impact Calculations) Tj
0 -15 Td
(D - Economic Benefit Quantification) Tj
0 -15 Td
(E - Curriculum Vitae) Tj
ET
endstream
endobj

5 0 obj
<<
/Type /Font
/Subtype /Type1
/BaseFont /Helvetica
>>
endobj

xref
0 6
0000000000 65535 f 
0000000009 00000 n 
0000000058 00000 n 
0000000115 00000 n 
0000000267 00000 n 
0000002419 00000 n 
trailer
<<
/Size 6
/Root 1 0 R
>>
startxref
2490
%%EOF